|
|
|
|
| Join Chief Editor Tom von Gunden and Drug Delivery experts to explore innovations in delivering complex and combination therapies, including drugs, biologics, and personalized medicines. Topics include nanoparticles, platform approaches, and delivery challenges for cell and gene therapies. Free registration—sign up today! |
|
|
|
|
By Drug Delivery Leader: Sit and Deliver | In this episode of Sit and Deliver, host Tom von Gunden talks with CEO John Climaco and Chief Medical Officer Dr. Sandra Silberman from CNS Pharmaceuticals about intravenously crossing the BBB to deliver classes of drugs, such as taxanes, proven in treating solid tumors in other locations. | |
|
|
Understanding Annex 1 For Sterile Medicinal Products | By Fran DeGrazio, executive editor, Drug Delivery Leader | Fran DeGrazio outlines key concepts from the EU Annex 1 guidance for sterile medicinal products. She highlights considerations for manufacturing and offers recommendations for contamination control, facilities upgrades, quality risk management, and inspections |
|
|
|
|
|
|
| Ophthalmic Drug Delivery | Article | By Dr. Tamas Solymosi, Nanoform | Explore the challenges to effective delivery of drugs to the eye, intricacies of ophthalmic drug delivery, and advantages of nanoparticles as an enabling technology for ocular drug-delivery systems. |
|
|
| A Blueprint For Breakthroughs: Accelerating Rare Disease Therapies | Article | By Dr. Rebecca Abram and Dr. Joanna Norman, FUJIFILM Biotechnologies | To manufacture your rare disease therapy cost effectively, partner with an experienced CDMO from the outset. The right partner will offer development, manufacturing, quality, and regulatory expertise. |
|
|
|
|
|
|
| The PDA Pharmaceutical Microbiology Conference 2025 marks two decades of advancing microbiological science and practice. This milestone event brings together the global microbiology community, including experts from industry, academia, and regulatory agencies, to explore the evolving landscape of pharmaceutical microbiology. This year's theme, Microbial Resilience: Today's Response, Tomorrow's Plan, reflects our focus on navigating present-day challenges while building robust strategies for the future. |
|
|
|
|
|
.png){kind=logo}
